According to a new report published by Allied Market Research, titled, “Ornithine Transcarbamylase Deficiency Treatment Market: Global Opportunity Analysis and Industry Forecast, 2021-2030” Ornithine transcarbamylase deficiency is a genetic disease causing ammonia accumulation in the blood. It is identified by a complete or partial lack of the enzyme called ornithine transcarbamylase in the patient’s body. …